checkAd

    DGAP-Adhoc  120  0 Kommentare Leadership Change in the Executive Board of Carl Zeiss Meditec AG

    DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
    Leadership Change in the Executive Board of Carl Zeiss Meditec AG

    30-Sep-2021 / 16:20 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    Leadership Change in the Executive Board of Carl Zeiss Meditec AG

    Jena, September 30, 2021

    The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has agreed on a change in the Executive Board of the company. Dr. Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will turn over his position to Dr. Markus Weber, currently member of the Executive Board of Carl Zeiss AG, on December 31, 2021. The transition is happening on the best of terms and at Dr. Monz' own request.

    Dr. Weber has more than 20 years of experience in various management and research and development functions within the ZEISS Group and, on the Executive Board of Carl Zeiss AG, is currently responsible for the Semiconductor Technology segment. Along with his new role as Chief Executive Officer of Carl Zeiss Meditec AG, Dr. Weber will remain on the board of Carl Zeiss AG, assuming the responsibilities of Dr. Monz on that board, who will leave the Executive Board of Carl Zeiss AG on December 31, 2021.

    In the view of the Supervisory Board of Carl Zeiss Meditec AG, management continuity is assured via the internal succession. The other two members of the Executive Board, Justus Felix Wehmer and Jan Willem de Cler, will remain in their current positions.
     
     

    Contact for investors and press
    Sebastian Frericks
    Head of Investor Relations
    Carl Zeiss Meditec AG
    Tel.: +49 3641 220-116
    E-Mail: investors.meditec@zeiss.com

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Carl Zeiss Meditec AG!
    Short
    102,63€
    Basispreis
    0,68
    Ask
    × 13,86
    Hebel
    Long
    91,68€
    Basispreis
    0,71
    Ask
    × 13,76
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.


    30-Sep-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: Carl Zeiss Meditec AG
    Göschwitzer Str. 51-52
    07745 Jena, Germany
    Germany
    Phone: +49 (0)3641 220-0
    Fax: +49 (0)3641 220-112
    E-mail: investors.meditec@zeiss.com
    Internet: www.zeiss.de/meditec-ag/ir
    ISIN: DE0005313704
    WKN: 531370
    Indices: MDAX, TecDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1237251

     
    End of Announcement DGAP News Service

    1237251  30-Sep-2021 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1237251&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc Leadership Change in the Executive Board of Carl Zeiss Meditec AG DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel Leadership Change in the Executive Board of Carl Zeiss Meditec AG 30-Sep-2021 / 16:20 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No …

    Schreibe Deinen Kommentar

    Disclaimer